Biopharma Daily Stock Updates - 03/30/21

Mar 30, 20211 min read

$XBI $130.11 +1%

$EQ +10% Ph 1b data. source

$BSGM +6% Awarded US patent. source

$IMAB +6% IND approved for solid tumors. source

$KRYS +5% Complete ph 3 enrollment. source

$FMTX -2% New ph 1 data & ph 2/3 initiation. source

$AMRN +4% EU approval of Vazkepa. source

$CARA +4% EMA accepted MAA for review, decision expected Q2 2022. source

$PRQR -12% Offering. source

$OVID +2% closed agreement with Takeda for TAK-935. source